Linezolid for treatment of chronic extensively drug-resistant tuberculosis.
Clinical Trial, Phase II
Randomized Controlled Trial
Research Support, N.I.H., Intramural
Research Support, Non-U.S. Gov't
Journal:The New England journal of medicine, Volume: 367, Issue: 16
Linezolid has antimycobacterial activity in vitro and is increasingly used for patients with highly drug-resistant tuberculosis.